Discover key insights and essential strategies for managing the legal intricacies involved in pioneering advancements within the life sciences sector. Equip yourself with the essential tools to navigate regulatory frameworks, protect intellectual property, and ensure compliance during each phase of research and development. Enhance your practice with practical, actionable guidance tailored for legal professionals driving innovation in the rapidly evolving life sciences landscape.
The Medicines and Healthcare products Regulatory Agency (MHRA) has issued updated guidance on clinical trials for medicines, outlining roles and...
This week's edition of Life Sciences weekly highlights includes analysis by Venner Shipley of the UK High Court decision to follow Medeva’s precedent...
The National Institute for Health and Care Excellence (NICE) has launched a public consultation on the proposed adoption of the new UK EQ-5D-5L value...
The European Commission has announced that the European Medicines Agency (EMA) will launch a pilot programme in Q2 2026 to support breakthrough...
Introduction to technology transfer agreements in the Life Sciences industryWhat is a technology transfer agreement?The term ‘technology transfer...
Regulation of cosmetic products in the UKThis Practice Note provides an overview of the UK regulatory framework for cosmetics. It sets out the legal...
Intellectual property protection for medical devicesChanges to intellectual property (IP) law from 1 January 2021Before discussing how intellectual...
Second and subsequent medical use patent claimsBackground to medical use claimsSecond (and subsequent) medical use patent claims are specific to the...
If a rentcharge is shown as being informally exonerated on title information, does this apply to the current registered owner? Or does the informal exoneration only apply to the parties to the document which informally exonerated the rentcharge?This Q&A considers the situation where, at some
If a beneficiary signs a deed of disclaimer of their share of an estate and the estate pays their legal fees, will that count as a PET against their estate?A disclaimer is the refusal of a gift prior to acceptance. The refusal of the gift must take place before the beneficiary accepts any benefit
Can shares in a limited company that have not been paid-up at all be cancelled?A limited company having a share capital may not alter that share capital, except in the ways listed in section 617 of the Companies Act 2006 (CA 2006). Shares in a company cannot simply be cancelled without following an
Template for regulatory references given by SMCR firms and disclosure requirements[Insert addressee details]Dear [insert name][It is our understanding that [insert name of prospective employee] [was an employee of yours between the dates of [insert dates as appropriate] OR is a current employee of
0330 161 1234